KAO JOHN E 4

What Happened
John E. Kao, CEO of Alignment Healthcare, sold 180,000 shares on 2026-02-10 in an open-market disposition. The filing reports a weighted-average sale price of $20.49 per share (range $20.23–$20.66), for total proceeds of $3,687,354. The trades were made under a pre-established Rule 10b5-1 trading plan adopted 03/12/2025.

Key Details

• Transaction date: 2026-02-10 (reported same day).
• Transaction type/code: Sale (S) — open market/private sale.
• Shares sold: 180,000; weighted-average price: $20.49; price range: $20.23 to $20.66.
• Proceeds: $3,687,354 (approximately $3.69M).
• Holdings after the sale: Not specified in the provided filing excerpt.
• Footnotes: F1 = 10b5-1 plan adoption date 03/12/2025; F2 = weighted-average price with per-trade prices available on request; F3 = securities are/were held by the JEK Trust (dated 2/8/2021), of which Mr. Kao is trustee.
• Filing timeliness: Report covers 2026-02-10 and was filed 2026-02-10 (no late filing indicated).

Context
This was a straight sale of shares (not an option exercise or award). Because it was executed under a 10b5-1 plan, the trades were prearranged and routine rather than an ad-hoc immediate signal of management sentiment. Retail investors should view this as a disclosed insider sale; it’s factual data rather than a direct recommendation.